Glad to be featured in the Market Map of the leading European healthcare companies 2022 curated by AlbionVC – which aims to
“Captures the entrepreneurial spirit and mission drive of founders in Europe seeking to fix what they see as broken healthcare systems.”
We could not agree more, as our mission is to improve the diagnostic process by leveraging the capabilities of Raman spectroscopy.
We have been listed within the digital pharma sector under Digital Biomarkers applied to pathology. But we can also confirm “a trend of the borders between segments starting to blur” as CRI technology relates also to imaging, diagnostic and clinical decision support.
More details: European HealthTech Market Map 2022